STERIS plc Payments of Merger Related Costs, Financing Activities
STERIS plc (STE) reported Payments of Merger Related Costs, Financing Activities of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2026-08-07
- STERIS plc payments of merger related costs, financing activities for the quarter ending 2026-06-30 was $100.00K, a 0.00% change year-over-year.
- STERIS plc payments of merger related costs, financing activities for the quarter ending 2026-03-31 was $100.00K, a 0.00% change year-over-year.
- STERIS plc payments of merger related costs, financing activities for the quarter ending 2025-12-31 was $100.00K, a 0.00% change year-over-year.
- STERIS plc payments of merger related costs, financing activities for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- STERIS plc payments of merger related costs, financing activities for fiscal 2026 was $400.00K, a 0.00% change from fiscal 2025.
- STERIS plc payments of merger related costs, financing activities for fiscal 2025 was $400.00K, a 93.55% decline from fiscal 2024.
- STERIS plc payments of merger related costs, financing activities for fiscal 2024 was $6.20M, a 321.48% increase from fiscal 2023.
- STERIS plc payments of merger related costs, financing activities for fiscal 2023 was $1.47M, a 95.50% decline from fiscal 2022.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month | Payments of Merger Related Costs, Financing Activities 3 month as first filed | Payments of Merger Related Costs, Financing Activities 6 month | Payments of Merger Related Costs, Financing Activities 6 month as first filed | Payments of Merger Related Costs, Financing Activities 9 month | Payments of Merger Related Costs, Financing Activities 9 month as first filed | Payments of Merger Related Costs, Financing Activities 12 month | Payments of Merger Related Costs, Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-07 | $200.00K derived: sum of 2 quarters · filed 2026-08-07 | $300.00K derived: sum of 3 quarters · filed 2026-08-07 | $400.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $200.00K derived: sum of 2 quarters · filed 2026-05-29 | $300.00K derived: sum of 3 quarters · filed 2026-05-29 | $400.00K 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $200.00K derived: sum of 2 quarters · filed 2026-02-06 | $300.00K 10-Q · filed 2026-02-06 | $400.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $200.00K 10-Q · filed 2025-11-06 | $300.00K derived: sum of 3 quarters · filed 2026-08-07 | $400.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-07 | $200.00K derived: sum of 2 quarters · filed 2026-08-07 | $300.00K derived: sum of 3 quarters · filed 2026-08-07 | $400.00K derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $200.00K derived: sum of 2 quarters · filed 2026-05-29 | $300.00K derived: sum of 3 quarters · filed 2026-05-29 | $400.00K 10-K · filed 2026-05-29 | $355.00K 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $200.00K derived: sum of 2 quarters · filed 2026-02-06 | $300.00K 10-Q · filed 2026-02-06 | $266.00K 10-Q · filed 2025-02-07 | $347.00K derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-09-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $200.00K 10-Q · filed 2025-11-06 | $177.00K 10-Q · filed 2024-11-07 | $247.00K derived: sum of 3 quarters · filed 2026-05-29 | $6.22M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-06-30 | $100.00K 10-Q · filed 2025-08-07 | $87.00K 10-Q · filed 2024-08-08 | $147.00K derived: sum of 2 quarters · filed 2026-05-29 | $6.12M derived: sum of 3 quarters · filed 2026-05-29 | $6.21M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $6.02M derived: sum of 2 quarters · filed 2026-05-29 | $6.11M derived: sum of 3 quarters · filed 2026-05-29 | $6.20M 10-K · filed 2026-05-29 | $6.24M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $5.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $6.06M derived: sum of 2 quarters · filed 2025-02-07 | $6.15M 10-Q · filed 2025-02-07 | $7.31M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $177.00K 10-Q · filed 2024-11-07 | $1.34M derived: sum of 3 quarters · filed 2025-05-29 | $1.50M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $89.00K 10-Q · filed 2024-08-08 | $1.25M derived: sum of 2 quarters · filed 2025-05-29 | $1.41M derived: sum of 3 quarters · filed 2025-05-29 | $1.48M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $1.32M derived: sum of 2 quarters · filed 2025-05-29 | $1.39M derived: sum of 3 quarters · filed 2025-05-29 | $1.47M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $226.00K derived: sum of 2 quarters · filed 2024-02-08 | $310.00K 10-Q · filed 2024-02-08 | $406.00K derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $69.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $153.00K 10-Q · filed 2023-11-07 | $249.00K derived: sum of 3 quarters · filed 2024-05-29 | $7.57M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $84.00K 10-Q · filed 2023-08-08 | $180.00K derived: sum of 2 quarters · filed 2024-05-29 | $7.50M derived: sum of 3 quarters · filed 2024-05-29 | $7.61M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $7.42M derived: sum of 2 quarters · filed 2024-05-29 | $7.53M derived: sum of 3 quarters · filed 2024-05-29 | $32.68M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | $7.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | $7.43M derived: sum of 2 quarters · filed 2023-02-08 | $32.58M 10-Q · filed 2023-02-08 | $32.01M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | $25.26M 10-Q · filed 2022-11-09 | $24.69M derived: sum of 3 quarters · filed 2023-05-26 | $27.61M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $25.15M 10-Q · filed 2022-08-08 | $24.58M derived: sum of 2 quarters · filed 2023-05-26 | $27.50M derived: sum of 3 quarters · filed 2023-05-26 | $27.52M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | -$573.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $2.35M derived: sum of 2 quarters · filed 2023-05-26 | $2.37M derived: sum of 3 quarters · filed 2023-05-26 | $2.40M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $2.95M derived: sum of 2 quarters · filed 2022-02-09 | $2.97M 10-Q · filed 2022-02-09 | $3.14M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $42.00K 10-Q · filed 2021-11-08 | $216.00K derived: sum of 3 quarters · filed 2022-05-31 | $216.00K derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $21.00K 10-Q · filed 2021-08-09 | $195.00K derived: sum of 2 quarters · filed 2022-05-31 | $195.00K derived: sum of 3 quarters · filed 2022-05-31 | $195.00K derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $174.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $174.00K derived: sum of 2 quarters · filed 2022-05-31 | $174.00K derived: sum of 3 quarters · filed 2022-05-31 | $626.00K 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $0.00 derived: sum of 2 quarters · filed 2021-02-09 | $452.00K 10-Q · filed 2021-02-09 | $502.00K derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | $452.00K 10-Q · filed 2020-11-06 | $502.00K derived: sum of 3 quarters · filed 2021-05-28 | $1.09M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $452.00K 10-Q · filed 2020-08-07 | $502.00K derived: sum of 2 quarters · filed 2021-05-28 | $1.09M derived: sum of 3 quarters · filed 2021-05-28 | $1.09M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $642.00K derived: sum of 2 quarters · filed 2021-05-28 | $642.00K derived: sum of 3 quarters · filed 2021-05-28 | $1.33M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $592.00K derived: sum of 2 quarters · filed 2020-02-10 | $1.28M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $685.00K 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $685.00K 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $2.06M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $9.92M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |